Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Medical Marijuana Inc News

    0,002 $ -4,76% -0,0001 $
    In : 0,0019 € | 23.04.24 21:59:30 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1C63S
    ISIN: US58463A1051
    US-Symbol: MJNA
    Typ: Aktie

    Medical Marijuana Inc News

    15.03.24 - PR Newswire
    Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings?
    Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings? PR Newswire
    26.10.21 - DGAP
    Kannaway(R), eine Tochtergesellschaft von Medical Marijuana, Inc., gewinnt Verfahren am obersten Verwaltungsgericht zum legalen Import von CBD-Öl nach Finnland
    DGAP-News: Medical Marijuana, Inc. / Schlagwort(e): Rechtssache Kannaway(R), eine Tochtergesellschaft von Medical Marijuana, Inc., gewinnt Verfahren am obersten ...
    06.07.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History
    Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History PR Newswire
    01.07.20 - PR Newswire
    Medical Marijuana, Inc. Reports 2020 First Quarter Financial and Operational Results
    Medical Marijuana, Inc. Reports 2020 First Quarter Financial and Operational Results PR Newswire
    30.06.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance
    Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance PR Newswire
    23.06.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited to Speak on Expert Panel About Cannabis in Mexico
    Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited to Speak on Expert Panel About Cannabis in Mexico PR Newswire
    11.06.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference
    Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference PR Newswire
    04.06.20 - PR Newswire
    Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors
    Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors PR Newswire
    28.05.20 - PR Newswire
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary ...
    22.05.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company
    Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company PR Newswire
    21.05.20 - PR Newswire
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker PR Newswire
    19.05.20 - PR Newswire
    Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards®
    Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards® PR Newswire
    11.05.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program
    Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-​Ever CBD Fitness Program PR Newswire
    07.05.20 - PR Newswire
    Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer
    Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer PR Newswire
    05.05.20 - PR Newswire
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files New U.S. Patent Application for Water-​Soluble Cannabinoid Molecules PR Newswire
    29.04.20 - PR Newswire
    Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-Over-Year and Positive Adjusted EBITDA
    Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-​Over-Year and ...
    22.04.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International
    Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International PR Newswire
    14.04.20 - PR Newswire
    Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President
    Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President PR Newswire
    09.04.20 - PR Newswire
    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™
    Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™ PR Newswire
    08.04.20 - PR Newswire
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine
    Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine PR Newswire

    Newssuche

    Videos

    newspaper
    08:50 Uhr
    Technical Trading: AUD/USD mit Mega Chance
    AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »